TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Xxlofoten AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
18,515
|
16,942
|
11,655 |
Financial expenses |
282
|
224
|
300 |
Earnings before taxes |
3,376
|
3,260
|
3,258 |
Total assets |
14,047
|
18,353
|
16,443 |
Current assets |
7,223
|
9,095
|
7,596 |
Current liabilities |
5,091
|
1,237
|
1,379 |
Equity capital |
4,312
|
11,734
|
9,224 |
- share capital |
2,459
|
2,620
|
2,765 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
30.7%
|
63.9%
|
56.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.2%
|
19.2%
|
28.0% |
Return on assets (ROA) |
26.0%
|
19.0%
|
21.6% |
Current ratio |
141.9%
|
735.2%
|
550.8% |
Return on equity (ROE) |
78.3%
|
27.8%
|
35.3% |
Change turnover |
2,614
|
5,899
|
4,707 |
Change turnover % |
16%
|
53%
|
68% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.